Search Results
Aug 31, 2026, 08:00 ET Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward
REHOVOT, Israel, Aug. 31, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneer in computational chemistry specializing in the generative design of small molecules for the pharmaceutical and agricultural industries,
More news about: Evogene
Aug 25, 2026, 07:00 ET Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees
MeetingREHOVOT, Israel, Aug. 25, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural
More news about: Evogene
Aug 18, 2026, 08:04 ET Evogene Reports Second Quarter and First Half 2026 Financial Results
REHOVOT, Israel, Aug. 18, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural
More news about: Evogene
Aug 14, 2026, 07:00 ET Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation
ETREHOVOT, Israel, Aug. 14, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural
More news about: Evogene
Jul 30, 2026, 07:00 ET Evogene Schedules Second Quarter 2026 Financial Results Release
REHOVOT, Israel, July 30, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural
More news about: Evogene
Jul 22, 2026, 08:00 ET Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases
REHOVOT, Israel and DAEJEON, South Korea, July 22, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in the generative design of small molecules for the pharmaceutical and agricultural
More news about: Evogene; ELEO Inc.
Jul 15, 2026, 07:30 ET AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ Capabilities
/PRNewswire/ -- AgPlenus Ltd., a company developing novel, sustainable crop protection products and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), today announced the launch of its Antifungal Potency Predictor (APP). This new machine learning model predicts the antifungal potency of small
More news about: AgPlenus Ltd.
Jul 08, 2026, 07:00 ET Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery
REHOVOT, ISRAEL and TEL AVIV, ISRAEL, July 8, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational chemistry company focused on the generative design of small molecules for the pharmaceutical and agricultural industries,
More news about: Evogene; Blavatnik Center for Drug Discovery
Jun 24, 2026, 08:00 ET Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and Optimization
success.REHOVOT, Israel, June 24, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a computational biology and chemistry company leveraging artificial intelligence (AI) to discover and develop innovative small-molecule products
More news about: Evogene
Jun 09, 2026, 07:00 ET Evogene to Present Its Pharma Division Achievements at the BIO International Convention
REHOVOT, Israel, June 9, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in AI-based generative design of small molecules for the pharmaceutical and agricultural
More news about: Evogene
Jun 02, 2026, 07:00 ET Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica
REHOVOT, Israel, June 2, 2026 /PRNewswire/ -- Evogene Ltd. ("Evogene") (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in generative design of small molecules for the pharmaceutical and agricultural industries,
More news about: Evogene
May 20, 2026, 07:00 ET Evogene Reports First Quarter 2026 Financial Results
REHOVOT, Israel, May 20, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative AI design of small molecules for the pharmaceutical and agricultural
More news about: Evogene
May 12, 2026, 08:00 ET Evogene to Present at the 24th Schrödinger European User Group Meeting
REHOVOT, Israel, May 12, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative AI design of small molecules for the pharmaceutical and agricultural
More news about: Evogene
May 07, 2026, 08:00 ET Evogene Schedules First Quarter 2026 Financial Results Release
REHOVOT, Israel, May 7, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural
More news about: Evogene
Apr 02, 2026, 16:01 ET Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
Market under the symbol "EVGN". It is further noted that the Letter from Nasdaq has no bearing on Evogene's listing on the Tel Aviv Stock Exchange, where its ordinary shares are traded under the ticker symbol "EVGN".About Evogene Ltd.Evogene Ltd. (Nasdaq/TASE: EVGN) is a pioneering company
More news about: Evogene
Mar 31, 2026, 08:00 ET Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock
("Casterra"), a developer of high-yield castor seed varieties and integrated castor farming solutions, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), today announced successful commercial field trials in Brazil, highlighting castor oil as a compelling candidate for economically viable biofuel
More news about: Casterra Ag Ltd.
Mar 09, 2026, 09:00 ET Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026
REHOVOT, Israel, March 9, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative AI design of small molecules for the pharmaceutical and agricultural
More news about: Evogene
Mar 05, 2026, 07:00 ET Evogene Reports Fourth Quarter and Full Year 2025 Financial Results
REHOVOT, Israel, March 5, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative AI design of small molecules for the pharmaceutical and agricultural
More news about: Evogene
Feb 25, 2026, 08:00 ET Evogene Releases CEO Letter to Shareholders
REHOVOT, Israel, Feb. 25, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in the generative AI design of small molecules for the pharmaceutical and agricultural
More news about: Evogene
Feb 19, 2026, 08:00 ET Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release
REHOVOT, Israel, Feb. 19, 2026 /PRNewswire/ -- Evogene Ltd . (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural
More news about: Evogene
Feb 17, 2026, 08:00 ET Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics
REHOVOT, Israel, Feb. 17, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in the generative design of small molecules for the pharmaceutical and agricultural
More news about: Evogene
Feb 11, 2026, 08:00 ET Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases
REHOVOT, Israel and MUNICH, Germany, Feb. 11, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in the generative design of small molecules for the pharmaceutical and agricultural
More news about: Evogene; Systasy; LMU University Hospital Munich
Feb 10, 2026, 13:20 ET Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds
REHOVOT, Israel and BOSTON, Feb. 10, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) ("Evogene" or the "Company"), a pioneering computational chemistry company, specializing in the generative design of small molecules for the
More news about: Evogene
Feb 10, 2026, 08:00 ET Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI™
REHOVOT, Israel, Feb. 10, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a computational chemistry company focused on AI-driven small-molecule design for the pharmaceutical and agricultural industries, today announced
More news about: Evogene
Feb 09, 2026, 08:00 ET Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board
REHOVOT, Israel, Feb. 9, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational chemistry company focused on the AI-driven discovery and design of novel small molecules for the pharmaceutical and agricultural
More news about: Evogene